A Case of Atrial Fibrillation Induced by Infliximab in a Patient with Rheumatoid Arthritis
Journal of Rheumatic Diseases
;
: 302-305, 2011.
Artigo
em Coreano
| WPRIM
| ID: wpr-186127
ABSTRACT
Infliximab, a chimeric monoclonal immunoglobulin antibody to tumor necrosis factor (TNF)-alpha is widely used in the treatment of rheumatoid arthritis (RA). The commonly reported cardiac side effects of infliximab include exacerbation of congestive heart failure, hypotension, and syncope. Cardiac arrhythmia and conduction disturbances have been reported only rarely in a few case reports and to the best of our knowledge, there are no previous reports on the occurrence of atrial fibrillation secondary to infliximab use in RA patients. Here, we report a case of acute atrial fibrillation with rapid ventricular response that occurred 24 hr after first dose of infliximab in a 55-year-old female patient with RA, who recovered to sinus rhythm after pharmacologic management.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Arritmias Cardíacas
/
Artrite Reumatoide
/
Fibrilação Atrial
/
Síncope
/
Imunoglobulinas
/
Fator de Necrose Tumoral alfa
/
Infliximab
/
Insuficiência Cardíaca
/
Hipotensão
/
Anticorpos Monoclonais
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS